Global Blood Therapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

View All

Latest Posts

About This Stock More About This Stock
These Were The Five Best And Worst Performing Mid-Cap Stocks In August 2022
Article By: ValueWalk
Tuesday, September 20, 2022 4:57 AM EDT
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
In this article: GET, SITM, NVAX, TNDM, CCXI, GBT, AXSM, KRTX, ASTS
Read
Small Cap Biotechs Perk Up On Dealmaking
Article By: Rod Raynovich
Saturday, August 6, 2022 9:38 PM EDT
With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.
In this article: PFE, AMGN, XBI, CCXI, GBT Also: MRNA, CRSP
Read
Global Blood Therapeutics Prices A $150.0 Million Common Stock Public Offering
Article By: NASDAQ GlobeNewswire
Friday, December 7, 2018 10:25 AM EDT
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $150.0 million.
In this article: GBT
Read
3 Top-Rated Stocks Trading At Steep Discounts
Article By: TipRanks
Sunday, June 24, 2018 5:18 AM EDT
With the market so volatile right now, there are plenty of savvy opportunities to be found. The key is to look for strong stocks that have been unfairly discounted by the market. Here are our three top picks.
In this article: MU, ALRM, GBT
Read
Global Blood Therapeutics Announces Full Exercise Of Underwriter’s Option To Purchase Additional Shares
Article By: NASDAQ GlobeNewswire
Monday, March 12, 2018 12:45 PM EDT
Global Blood Therapeutics, Inc. today announced that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 600,000 shares of GBT’s common stock.
In this article: GBT
Read
All Posts

Latest Tweets for $GBT

No tweets yet!

PARTNER HEADLINES